Table 2.
Characteristics of vaccine breakthroughs.
| Patient | Age | Sex | PCR results for SARS-CoV-2 | Condition | Time from vaccination to symptoms (days) | Time from symptoms to hospitalization (days) | Length of stay (days) | Vital status at one month |
|---|---|---|---|---|---|---|---|---|
| 1 | 75 | M | + | Splenectomy Cirrhosis Multiple myeloma |
3 | 6 | 25 | Alive |
| 2 | 79 | F | + | Splenectomy Kidney transplant |
14 | 4 | 23 | Alive |
| 3 | 42 | F | + | Cardiac condition Kidney transplant Obesity |
18 | 4 | 13 | Alive |
| 4 | 82 | M | + | Multiple myeloma Renal failure |
37 | 4 | 31 | Alive |
| 5 | 87 | M | − | Cardiac condition Renal failure Multiple myeloma |
60 | 2 | 28 | Death |